BioXcel Therapeutics, Inc. (BTAI)
NASDAQ: BTAI · IEX Real-Time Price · USD
1.120
-0.050 (-4.27%)
Jul 2, 2024, 4:00 PM EDT - Market closed
BioXcel Therapeutics Stock Forecast
BTAI's stock price has decreased by -85.79% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 6 analysts with 12-month price forecasts for BTAI stock have an average target of 6.00, with a low estimate of 4.00 and a high estimate of 10. The average target predicts an increase of 435.71% from the current stock price of 1.12.
Analyst Consensus: Buy
* Price targets were last updated on May 10, 2024.
Analyst Ratings
The average analyst rating for BTAI stock from 8 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 5 | 6 | 5 | 5 | 5 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 8 | 8 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +792.86% | May 10, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +792.86% | Apr 23, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $11 | Strong Buy | Reiterates | $11 | +882.14% | Mar 18, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $18 → $7 | Strong Buy | Maintains | $18 → $7 | +525.00% | Mar 14, 2024 |
| B of A Securities | B of A Securities | Strong Buy Maintains $8 → $7 | Strong Buy | Maintains | $8 → $7 | +525.00% | Mar 13, 2024 |
Financial Forecast
Revenue This Year
3.20M
from 1.38M
Increased by 131.59%
Revenue Next Year
9.90M
from 3.20M
Increased by 209.79%
EPS This Year
-2.59
from -6.15
EPS Next Year
-1.72
from -2.59
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 3.7M | 12.4M | 26.3M | 110.0M | 183.3M |
| Avg | 3.2M | 9.9M | 21.0M | 65.0M | 108.3M |
| Low | 2.0M | 7.3M | 13.7M | 22.1M | 37.0M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 168.6% | 286.5% | 165.1% | 422.9% | 182.2% |
| Avg | 131.6% | 209.8% | 112.6% | 208.7% | 66.7% |
| Low | 44.1% | 126.9% | 38.6% | 5.2% | -43.0% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -2.09 | -1.11 | -0.68 | -0.91 | -0.22 |
| Avg | -2.59 | -1.72 | -1.41 | -0.89 | -0.21 |
| Low | -3.03 | -2.74 | -2.57 | -0.85 | -0.21 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.